2026 Masahito Yamada: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	78	17831	16760	569	537	469	32786

Masahito Yamada publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Masahito Yamada sits on this spectrum.

101 publications 1,796+

This scientist: 469 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Masahito Yamada D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Masahito Yamada sits on this spectrum.

70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Masahito Yamada is affiliated with Kanazawa University in Japan, focusing on research in Medicine with a particular emphasis on Neurology, Molecular Biology, Physiology, Psychiatry and Mental Health, and Cognitive Neuroscience.

The primary themes in Yamada's scientific work include:

Alzheimer's disease research and treatments
Prion diseases and protein misfolding
Dementia and cognitive impairment research
Intracerebral and subarachnoid hemorrhage research
Neurological diseases and metabolism
Medicinal plants and neuroprotection
Amyloidosis: diagnosis, treatment, outcomes

Yamada has frequently published in several scientific venues, contributing notably to:

Scientific Reports
Journal of the Neurological Sciences
Journal of Alzheimer's Disease
PLoS ONE
Neuropathology

Key recent papers feature significant topics related to neurodegenerative diseases and neurological disorders. These papers include:

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease, 2020, Brain
Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD), 2020, Environmental Health and Preventive Medicine
State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease, 2021, Alzheimer's & Dementia
Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy, 2020, Journal of Neuropathology & Experimental Neurology
Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway, 2021, npj Science of Food

Yamada collaborates extensively with a number of researchers in related fields. Frequent coauthors include:

Tsuyoshi Hamaguchi
Kenjiro Ono
Kenji Sakai
Moeko Noguchi-Shinohara
Kazuo Iwasa

Best Publications

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre

5905
Citations
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

4225
Citations
Primary age-related tauopathy (PART): a common pathology associated with human aging

John F. Crary;John Q. Trojanowski;Julie A. Schneider;Jose F. Abisambra

1580
Citations
Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro

Kenjiro Ono;Kazuhiro Hasegawa;Hironobu Naiki;Masahito Yamada

1228
Citations
Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

Kenjiro Ono;Yuji Yoshiike;Akihiko Takashima;Kazuhiro Hasegawa

810
Citations
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion

Ryuichiro Atarashi;Katsuya Satoh;Kazunori Sano;Takayuki Fuse

682
Citations
REVIEW: Curcumin and Alzheimer's disease.

Tsuyoshi Hamaguchi;Tsuyoshi Hamaguchi;Kenjiro Ono;Masahito Yamada

518
Citations
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

Gabor G. Kovacs;Isidro Ferrer;Lea T. Grinberg;Lea T. Grinberg;Irina Alafuzoff

516
Citations
Phenolic Compounds Prevent Alzheimer’s Pathology through Different Effects on the Amyloid-β Aggregation Pathway

Tsuyoshi Hamaguchi;Kenjiro Ono;Atsushi Murase;Masahito Yamada

456
Citations
Quantifying prion disease penetrance using large population control cohorts

Eric Vallabh Minikel;Eric Vallabh Minikel;Sonia M. Vallabh;Sonia M. Vallabh;Monkol Lek;Monkol Lek;Karol Estrada;Karol Estrada

431
Citations
Cerebral amyloid angiopathy: An overview

Masahito Yamada

257
Citations
Prospective 10-year surveillance of human prion diseases in Japan

Ichiro Nozaki;Tsuyoshi Hamaguchi;Nobuo Sanjo;Moeko Noguchi-Shinohara

240
Citations
High-speed atomic force microscopy reveals structural dynamics of amyloid β1–42 aggregates

Takahiro Watanabe-Nakayama;Kenjiro Ono;Masahiro Itami;Ryoichi Takahashi

238
Citations
A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies

M Yoshita;J Taki;M Yamada

233
Citations
Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease.

Kenjiro Ono;Tsuyoshi Hamaguchi;Hironobu Naiki;Masahito Yamada

222
Citations
Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

James A.R. Nicoll;Masahito Yamada;Janusz Frackowiak;Bozena Mazur-Kolecka

222
Citations
Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD

M. Yoshita;J. Taki;K. Yokoyama;M. Noguchi-Shinohara

205
Citations
Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement

Tokuhei Ikeda;Kazuya Takahashi;Tamon Kabata;Daigo Sakagoshi

190
Citations
Consumption of Green Tea, but Not Black Tea or Coffee, Is Associated with Reduced Risk of Cognitive Decline

Moeko Noguchi-Shinohara;Sohshi Yuki;Chiaki Dohmoto;Yoshihisa Ikeda

185
Citations
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians

Akinori Miyashita;Asako Koike;Gyungah Jun;Li-San Wang

183
Citations

Frequent Co-Authors

Hidehiro Mizusawa Tokyo Medical and Dental University

Hironobu Naiki University of Fukui

Hitoshi Takahashi Niigata University

David B. Teplow University of California, Los Angeles

Akiyoshi Kakita Niigata University

Koichi Wakabayashi Hirosaki University

Hiroyuki Arai University of Tokyo

Gabor G. Kovacs University of Toronto

Akihiko Takashima Gakushuin University

Shoji Tsuji University of Tokyo

External Links

Personal website of Masahito Yamada

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Interested in medical careers beyond the traditional MD? There are several rewarding online degree options and career pathways in U.S. healthcare. For those keen on driving positive change in hospitals or clinics, pursuing the cheapest online master degree in healthcare administration can open doors to leadership roles in healthcare management and policy.

Nurses aiming to expand clinical expertise and leadership opportunities may consider the best online bsn to dnp programs, which help prepare advanced practitioners, educators, and nurse leaders. If your passion lies in pharmacy, earning an online pharmacist degree provides the flexibility to study while balancing work or family, qualifying graduates for pharmacist licensure.

Furthermore, the digital transformation in healthcare creates high demand for skilled professionals in health data management. Online him programs train students to manage electronic health records and protect sensitive information. Each of these online pathways offers flexible, affordable steps toward a growing and meaningful healthcare career.